First-in-Human Study of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy - Emerging Clinical Trial Results
AES Poster | 2023

NRTX-1001: Human inhibitory neuron cell therapy suppresses seizures and reduces histopathology in mouse model of chronic focal epilepsy with high repeatability across multiple studies and manufacturing lots
SfN Poster | 2023

Behavioral analyses in the immunodeficient NOG mouse after intrahippocampalkainic acid induction of chronic epileptic seizures
SfN Poster | 2023

First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy-Emerging Clinical Trial Results
AAN Poster | 2023

A Phase I/II Clinical Trial of NRTX-1001 HPSC-Derived Inhibitory Interneuron Cell Therapy for Chronic Focal Epilepsy
ISSCR | 2023

NRTX-1001: First-In-Class Human Inhibitory Neuron Cell Therapy For Phase I/II Clinical Investigation in Chronic Focal Epilepsy
AES Poster | 2022